Global Medical 3D Bioprinting Market Growth (Status and Outlook) 2025-2031

The global Medical 3D Bioprinting market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

Medical 3D bioprinting is the use of 3D printing-like techniques to combine cells, growth factors or biological materials to create biomedical parts, often with the aim of mimicking natural tissue characteristics. In general, 3D bioprinting can utilize a layer-by-layer approach to deposit materials called bioinks to create tissue-like structures that are subsequently used in various fields of medicine and tissue engineering. Bioprinting covers a wide range of bioprinting techniques and biomaterials. Currently, bioprinting can be used to print tissue and organ models to aid in the study of drugs and potential treatments.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

LPI (LP Information)' newest research report, the “Medical 3D Bioprinting Industry Forecast” looks at past sales and reviews total world Medical 3D Bioprinting sales in 2024, providing a comprehensive analysis by region and market sector of projected Medical 3D Bioprinting sales for 2025 through 2031. With Medical 3D Bioprinting sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Medical 3D Bioprinting industry.

This Insight Report provides a comprehensive analysis of the global Medical 3D Bioprinting landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Medical 3D Bioprinting portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Medical 3D Bioprinting market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Medical 3D Bioprinting and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Medical 3D Bioprinting.

This report presents a comprehensive overview, market shares, and growth opportunities of Medical 3D Bioprinting market by product type, application, key players and key regions and countries.

Segmentation by Type:
SLA
FDM
LOM
Others

Segmentation by Application:
Medical Device Manufacturers
Pharmaceutical Companies
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
3D Systems
GE Healthcare
ExOne
Electro Optical Systems
Renishaw
Stratasys
EnvisionTEC
Cyfuse Biomedical
Formlabs
Organovo Holdings
Allevi
Advanced Solutions
Aspect Biosystems
CELLINK
GeSiM
Bio3D Technologies
Regenovo Biotechnology
Optomec
Mecuris
Fluicell
BigRep

Please note: The report will take approximately 2 business days to prepare and deliver.